PX-18 Protects Human Saphenous Vein Endothelial Cells under Arterial Blood Pressure

Ann Vasc Surg. 2017 Jul:42:293-298. doi: 10.1016/j.avsg.2016.10.063. Epub 2017 Mar 11.

Abstract

Background: Arterial blood pressure-induced shear stress causes endothelial cell apoptosis and inflammation in vein grafts after coronary artery bypass grafting. As the inflammatory protein type IIA secretory phospholipase A2 (sPLA2-IIA) has been shown to progress atherosclerosis, we hypothesized a role for sPLA2-IIA herein.

Methods: The effects of PX-18, an inhibitor of both sPLA2-IIA and apoptosis, on residual endothelium and the presence of sPLA2-IIA were studied in human saphenous vein segments (n = 6) perfused at arterial blood pressure with autologous blood for 6 hrs.

Results: The presence of PX-18 in the perfusion blood induced a significant 20% reduction in endothelial cell loss compared to veins perfused without PX18, coinciding with significantly reduced sPLA2-IIA levels in the media of the vein graft wall. In addition, PX-18 significantly attenuated caspase-3 activation in human umbilical vein endothelial cells subjected to shear stress via mechanical stretch independent of sPLA2-IIA.

Conclusions: In conclusion, PX-18 protects saphenous vein endothelial cells from arterial blood pressure-induced death, possibly also independent of sPLA2-IIA inhibition.

MeSH terms

  • Alkanesulfonic Acids / pharmacology*
  • Apoptosis / drug effects
  • Arterial Pressure*
  • Cells, Cultured
  • Endothelial Cells / drug effects*
  • Endothelial Cells / enzymology
  • Endothelial Cells / pathology
  • Group II Phospholipases A2 / antagonists & inhibitors*
  • Group II Phospholipases A2 / metabolism
  • Human Umbilical Vein Endothelial Cells / drug effects
  • Human Umbilical Vein Endothelial Cells / enzymology
  • Human Umbilical Vein Endothelial Cells / pathology
  • Humans
  • Mechanotransduction, Cellular / drug effects*
  • Oleic Acids / pharmacology*
  • Phospholipase A2 Inhibitors / pharmacology*
  • Saphenous Vein / drug effects*
  • Saphenous Vein / enzymology
  • Saphenous Vein / pathology
  • Time Factors

Substances

  • 2-(N,N-bis(oleoyloxyethyl)amino)-1-ethanesulfonic acid
  • Alkanesulfonic Acids
  • Oleic Acids
  • Phospholipase A2 Inhibitors
  • Group II Phospholipases A2
  • PLA2G2A protein, human